INTELLIPHARMACEUTICS INTERNA (IPCI.CA) Forecast, Price Target & Analyst Ratings
TSX:IPCI • CA4581733090
0.08 CAD
-0.01 (-11.11%)
Last: Mar 5, 2024, 07:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for INTELLIPHARMACEUTICS INTERNA (IPCI.CA).
Forecast Snapshot
Consensus Price Target
CA$0.00
-100.00% Downside
Next Earnings Forecast
Release DateN/A
ChartMill Buy Consensus
42.22%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
CA$0.00
Upside
-100.00%
From current price of CA$0.08 to mean target of CA$0.00, Based on 9 analyst forecasts
Low
CA$0.00
Median
CA$0.00
High
CA$0.00
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
42.22%
IPCI.CA was analyzed by 9 analysts. The buy percentage consensus is at 42. So analysts seem to be rather negative about IPCI.CA.
In the previous month the buy percentage consensus was at a similar level.
IPCI.CA was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
Release DateN/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 1.4M -59.77% | -100.00% | 65.73K | |
| EBITDA YoY % growth | -4.26M 41.80% | -3.912M 8.18% | -2.644M 32.39% | |
| EBIT YoY % growth | -4.68M 40.23% | -4.173M 10.83% | -2.851M 31.69% | |
| Operating Margin | -334.29% | N/A | -4,336.70% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A